David Main

President & Chief Executive Officer @ Notch Therapeutics arrow icon

loader linkedin icon See Linkedin

Known information

  • Co-founded Aquinox Pharmaceuticals in 2006
  • Led Aquinox Pharmaceuticals through its transition from a private to a NASDAQ-listed public company
  • Oversaw the merger of Aquinox Pharmaceuticals with Neoleukin Therapeutics
  • Formerly served as President and CEO of INEX Pharmaceuticals
  • Previously worked as a Vice President at QLT
  • Served as the Chair of LifeSciences BC, BIOTECanada, and Accel-Rx
  • Was a Director of BIO.org
  • Began his career as a licensed pharmacist at the Royal Columbian Hospital in New Westminster, B.C.
  • Holds a BSc in Pharmacy and an MBA from the University of British Columbia

About Notch Therapeutics

Notch Therapeutics is a biotechnology company that develops cellular immunotherapies for cancer treatment, utilizing a proprietary platform to engineer pluripotent stem cells into therapeutic cells.

report flag Report inaccurate information

People similar to David Main

Chris Bond

Chief Scientific Officer @ Notch Therapeutics

Kamran Alam

Executive Vice President, Finance & Chief Financial Officer @ Notch Therapeutics

Timothy Key

Director, Business Operations @ Notch Therapeutics

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free